Revelation Biosciences CFO granted 208K share award
REVELATION BIOSCIENCES, INC.
Rhea-AI Filing Summary
REVELATION BIOSCIENCES, INC. (REVB) reported that its Chief Financial Officer, Chester S. Zygmont III, received a restricted stock award of 208,073 shares of Common Stock under the company’s 2021 Equity Incentive Plan. The award vests with 50% on the two-year anniversary of the grant date and the remaining 50% on the four-year anniversary, subject to continued service and possible acceleration upon performance milestones. On the same date, Zygmont made a bona fide gift of 208,073 shares to The Zygmont Family Trust, which now holds 300,136 shares indirectly, and an affiliated LLC holds an additional 2 shares indirectly.
Positive
- None.
Negative
- None.
Insider Trade Summary
416,146 shares gifted
Gift
4 txns
Insider
Zygmont Chester Stanley III
Role
Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock F1 | 208,073 | $0.00 | $0.00 |
| Gift | Common Stock F1 | 208,073 | $0.00 | $0.00 |
| Gift | Common Stock F1, F2 | 208,073 | $0.00 | $0.00 |
| holding | Common Stock F3 | -- | -- | -- |
Holdings After Transaction:
Common Stock — 0 shares (Direct);
Common Stock — 300,136 shares (Indirect, by Trust);
Common Stock — 2 shares (Indirect, by LLC)
Footnotes (3)
- F1. These shares are subject to a restricted stock award granted under the Revelation Biosciences, Inc. 2021 Equity Incentive Plan, with 50% of the shares vesting on the two-year anniversary of the grant date, and the remaining 50% of the shares vesting on the four-year anniversary of the grant date, provided that the Reporting Person remains continuously employed by or provides services to the Company or any subsidiary through the applicable vesting date; and provided, further that such vesting could be accelerated upon the achievement of certain performance milestones.
- F2. Shares are held by The Zygmont Family Trust Dated October 25, 2016, with respect to which Chester S Zygmont III is a trustee.
- F3. Shares are held by Czeslaw Capital Fund, LLC. Chester S Zygmont III is the sole manager of Czeslaw Capital Fund, LLC.
Key Figures
Restricted stock award: 208,073 shares
Award vesting schedule first tranche: 50%
Award vesting schedule second tranche: 50%
+5 more
8 metrics
Restricted stock award
208,073 shares
Common Stock granted under the Revelation Biosciences, Inc. 2021 Equity Incentive Plan on 2026-08-17
Award vesting schedule first tranche
50%
Portion of restricted shares vesting on the two-year anniversary of the grant date
Award vesting schedule second tranche
50%
Portion of restricted shares vesting on the four-year anniversary of the grant date
Gifted shares
208,073 shares
Bona fide gift of Common Stock on 2026-08-17 associated with transfer to family trust
Shares held by family trust after transaction
300,136 shares
Indirect holdings of Common Stock by The Zygmont Family Trust after gift transaction
Shares held by LLC
2 shares
Indirect holdings of Common Stock by Czeslaw Capital Fund, LLC
Gift transactions count
2
Total number of bona fide gift transactions reported in the filing
Gifted shares total
416,146 shares
Aggregate number of shares involved in gift transactions as summarized in transactionSummary
Key Terms
restricted stock award, 2021 Equity Incentive Plan, bona fide gift, vesting, +1 more
5 terms
restricted stock award financial
"These shares are subject to a restricted stock award granted under the Revelation"
A restricted stock award is company shares given to an employee or executive that cannot be sold or fully owned until certain conditions—like staying with the company for a set time or hitting performance targets—are met. Think of it as a gift that only becomes yours after you fulfill specific obligations; for investors, these awards matter because they can increase the total shares outstanding when they vest, reveal how management is being paid and motivated, and create potential selling pressure when restrictions lift.
2021 Equity Incentive Plan financial
"stock award granted under the Revelation Biosciences, Inc. 2021 Equity Incentive Plan"
bona fide gift financial
"transaction_code_description": "Bona fide gift""
A bona fide gift is a genuine, voluntary transfer of money, property, or benefits from one party to another made without expectation of repayment, services, or hidden conditions. Investors care because such gifts can affect company disclosures, related‑party transaction rules, tax treatment, and perceived conflicts of interest; think of it like someone giving you a present with no strings attached — but on a corporate scale, auditors and regulators need to verify it really is unconditional.
vesting financial
"with 50% of the shares vesting on the two-year anniversary of the grant date"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
indirect ownership financial
"direct_or_indirect": "I","nature_of_ownership": "by Trust""
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity award did REVB’s CFO receive according to this Form 4?
The CFO received a restricted stock award of 208,073 shares of Common Stock under Revelation Biosciences’ 2021 Equity Incentive Plan, vesting 50% after two years and 50% after four years, subject to continued service and potential performance-based acceleration.
What gift transactions involving REVB stock did the CFO report?
The CFO reported a bona fide gift of 208,073 shares of Common Stock. These shares were transferred to The Zygmont Family Trust, which is associated with the CFO as a trustee, changing the form of ownership from direct to indirect through the trust.
What additional indirect REVB holdings are associated with the CFO?
Beyond the trust, an entity named Czeslaw Capital Fund, LLC holds 2 shares of Revelation Biosciences Common Stock indirectly. Chester S. Zygmont III is disclosed as the sole manager of Czeslaw Capital Fund, LLC.
AI-generated analysis. How Rhea-AI works. Not financial advice.
